Nephros Inc

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nephros Inc reports first profitable quarter, eyes growth opportunities

Nephros Inc delivered a strong performance in Q3 2024, achieving profitability and operational efficiency gains.
While facing revenue challenges and liquidity concerns, the company's strategic initiatives and focus on financial discipline position it for growth.
Opportunities in new markets and customer engagement through digital tools provide avenues for future expansion.
Balancing growth pursuits with financial prudence will be crucial for Nephros Inc's sustained success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nephros, Inc. (NASDAQ:NEPH ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - President & Chief Executive Officer Judy Krandel - Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group Ralph Weil - R. Weil Investment Management Operator Good day, and welcome to the Nephros Inc. Third Quarter 2024 Financial Results Conference Call.

Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript

SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules Third Quarter 2024 Financial Results Conference Call

SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which devastated parts of the southeastern United States. Leveraging its significant disaster and emergency response capabilities, Nephros provided crucial water filtration solutions to multiple healthcare and nursing care facilities affected by the storms, ensuring a safe supply of water to patients and staff amid recovery efforts.

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript

Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2024. Financial Highlights* Net revenue of $3.3 million, a decrease of 8% over Q2 prior year; programmatic revenue (excluding emergency response revenue) increased 8% over Q2 prior year Net loss of $0.3 million, compared to a net loss of $0.4 million Adjusted EBITDA of ($133,000), compared to ($183,000) *Stated performance is relative to same period in the prior year unless otherwise noted.

Nephros Announces Financial Results for Quarter Ended June 30, 2024

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules Second Quarter 2024 Financial Results Conference Call

Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ET

Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial Highlights Fourth Quarter Ended December 31, 2023 Net revenue from continuing operations was $3.3 million, compared to $2.6 million in the fourth quarter of 2022, up 27% Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2022 Adjusted EBITDA from continuing operations was ($0.1 million), compared to ($0.5 million) in the fourth quarter of 2022, an improvement of 89% Year-End 2023 Net revenue from continuing operations was $14.2 million, compared with $10.0 million in 2022, up 43% Net loss from continuing operations was ($1.6 million), compared with ($4.3 million) in 2022 Adjusted EBITDA from continuing operations was ($0.1 million), compared with ($2.4 million) in 2022, an improvement of 97% “2023 was an exciting year for Nephros.

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Nephros, Inc. (NASDAQ:NEPH ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - Chief Financial Officer Andy Astor - Advisor and Interim CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon and welcome to the Nephros Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript

Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities

Nephros Announces Results for Quarter Ended September 30, 2023

SOUTH ORANGE, NJ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer (CFO), effective today. In this role, Ms. Krandel will be responsible for directing the company's finances and working closely with the Chief Executive Officer (CEO) and Board of Directors to develop and execute Nephros's long-term strategy.

Nephros Hires Judy Krandel as Chief Financial Officer

SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 8, 2023 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules Third Quarter 2023 Financial Results Conference Call

South Orange, New Jersey--(Newsfile Corp. - September 19, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be presenting at the 16th annual Main Event on Tuesday, October 3rd at 9:00 AM PT at the Luxe Sunset Boulevard Hotel. Robert Banks, President & CEO, will be giving the presentation.

Nephros to Present at LD Micro Main Event XVI

Nephros, Inc. (NASDAQ:NEPH ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Andy Astor - Advisor and Interim CFO Conference Call Participants Thomas McGovern - Maxim Group Robert Smith - Center for Performance Investing Operator Good afternoon, everyone, and welcome to the Nephros Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript

Second -Quarter Net Revenue of $ 3. 5 Millio n , a 24% Increase Over 2022 ; Year-to-Date Revenue Increase s 4 5 %; Maintains Positive Cash Flow Results

Nephros Announces Results for Quarter Ended June 30, 2023

SOUTH ORANGE, NJ, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 9, 2023 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

South Orange, New Jersey--(Newsfile Corp. - May 24, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that Andy Astor, Advisor and Interim Chief Financial Officer of Nephros, has been selected to present at the LD Micro Invitational XIII on Wednesday June 7, 2023 at 9:00am PT at the Luxe Sunset Boulevard Hotel in Los Angeles. Event: LD Micro Invitational XIII Date: June 6-8th, 2023 Presentation: June 7th at 9:00am PT Virtual Registration: https://ldinv13.sequireevents.com *1x1s available for qualified investors About Nephros Nephros is committed to improving the human relationship with water through leading, accessible technology.

Nephros to Present at LD Micro Invitational XIII

First-Quarter Net Revenue of $ 3.7 Millio n; Achieves Positive Cash Flow Months Earlier than Forecast

Nephros Announces Results for Quarter Ended March 31, 2023

Robert Banks to Be Named President and Chief Executive Officer;Andy Astor to Remain as Advisor and Interim Chief Financial Officer

Nephros Announces CEO Retirement and Succession Plan

SOUTH ORANGE, NJ , April 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10, 2023 after market close and will host a conference call that same day at 4:30pm ET.

Nephros Schedules First Quarter 2023 Financial Results Conference Call

SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023.

Nephros Announces Preliminary Results for First Quarter 2023

Nephros, Inc. (NASDAQ:NEPH ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Andrew Astor - President and CEO Conference Call Participants Anthony Vendetti - Maxim Group Joseph Schuler - JAS Investors Operator Good afternoon, and welcome to the Nephros Inc. Fourth Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

Nephros, Inc. (NEPH) Q4 2022 Earnings Call Transcript

Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million

Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Donastar Becomes Exclusive Master Distributor of Nephros Commercial Water Filters for Food & Beverage and Hospitality Markets

News for Nephros Inc Stock (NEPH)